Joy Goswami
Special to the USA TODAY Network
At the outbreak of the pandemic, no one could have predicted that Americans would have access to three highly effective vaccines within a year.
No one, that is, except our nation s scientists. Researchers at Pfizer, Moderna and Johnson & Johnson were uniquely prepared to fast-track the development of these breakthroughs, thanks largely to the legal infrastructure that encourages companies to make risky bets on cutting-edge technologies.
For decades now, America s scientific and technological prowess has been the envy of the world. But that wasn t always the case. Developing transformative technologies often requires partnerships between those in academia, who do much of the early stage, basic research that moves scientific understanding forward, and those in the private sector, who can risk tremendous capital to explore real-world applications for those discoveries.
UGA diversity initiative includes dialogue training
5 hours ago
Faculty and staff program will help build supportive campus community.
A University of Georgia pilot program launching this month involving faculty and staff will further the university’s efforts to foster a more welcoming and supportive campus community.
Based on recommendations issued by the Presidential Taskforce on Race, Ethnicity, and Community, a committee established by UGA President Jere W. Morehead in 2020, the university is implementing a pilot Reflective Structured Dialogue (RSD) training, beginning this year with two groups of UGA faculty and staff.
RSD builds the capacity of communities and organizations to engage, live and thrive despite their differences through a dialogue process that shifts the goal of conversation from problem solving to mutual understanding.